
2023-2029 Global Hematology and Coagulation Industry Research & Trends Analysis Report
The research report on ‘Hematology and Coagulation Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the latest research analysis,the global market for Hematology and Coagulation should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Hematology and Coagulation market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Hematology and Coagulation market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Hematology segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Children has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Hematology and Coagulation include Abbott Diagnostics, Beckman Coulter, Inc., CellaVision AB, Diagnostica Stago, S.A.S., DIAGON Kft. Hungary, HemoCue, Horiba Medical, Medica Corporation and Microvisk Technologies, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Hematology and Coagulation.
Data-Driven Insights: Highlights from Our Report
(1) Global Hematology and Coagulation market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Hematology and Coagulation market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Hematology and Coagulation market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Hematology and Coagulation segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Hematology and Coagulation segment by type and by application and regional segment by type and by application.
(6) Hematology and Coagulation industry supply chain, upstream, midstream and downstream analysis.
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Understanding Market Segments by Type: A Comparative Analysis
Hematology
Coagulation
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
Children
Adult
Understanding Market Segments by Key Players: Insights and Opportunities
Abbott Diagnostics
Beckman Coulter, Inc.
CellaVision AB
Diagnostica Stago, S.A.S.
DIAGON Kft. Hungary
HemoCue
Horiba Medical
Medica Corporation
Microvisk Technologies
Mindray
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Werfen (Instrumentation Laboratory, Accriva Diagnostics)
West Medica
1 Market Overview
1.1 Product Overview and Scope of Hematology and Coagulation
1.2 Global Hematology and Coagulation Market Size and Forecast
1.3 China Hematology and Coagulation Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Hematology and Coagulation Share in Global Market, 2018-2029
1.4.2 Hematology and Coagulation Market Size: China VS Global, 2018-2029
1.5 Hematology and Coagulation Market Dynamics
1.5.1 Hematology and Coagulation Market Drivers
1.5.2 Hematology and Coagulation Market Restraints
1.5.3 Hematology and Coagulation Industry Trends
1.5.4 Hematology and Coagulation Industry Policy
2 Global Competitive Situation by Company
2.1 Global Hematology and Coagulation Revenue by Company (2018-2023)
2.2 Global Hematology and Coagulation Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Hematology and Coagulation Concentration Ratio
2.4 Global Hematology and Coagulation Mergers & Acquisitions, Expansion Plans
2.5 Global Hematology and Coagulation Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Hematology and Coagulation Revenue by Company (2018-2023)
3.2 China Hematology and Coagulation Hematology and Coagulation Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Hematology and Coagulation, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Hematology and Coagulation Industry Chain
4.2 Hematology and Coagulation Upstream Analysis
4.3 Hematology and Coagulation Midstream Analysis
4.4 Hematology and Coagulation Downstream Analysis
5 Sights by Type
5.1 Hematology and Coagulation Classification
5.1.1 Hematology
5.1.2 Coagulation
5.2 By Type, Global Hematology and Coagulation Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Hematology and Coagulation Revenue, 2018-2029
6 Sights by Application
6.1 Hematology and Coagulation Segment by Application
6.1.1 Children
6.1.2 Adult
6.2 By Application, Global Hematology and Coagulation Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Hematology and Coagulation Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Hematology and Coagulation Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Hematology and Coagulation Market Size, 2018-2029
7.3 North America
7.3.1 North America Hematology and Coagulation Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Hematology and Coagulation Market Size Market Share
7.4 Europe
7.4.1 Europe Hematology and Coagulation Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Hematology and Coagulation Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Hematology and Coagulation Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Hematology and Coagulation Market Size Market Share
7.6 South America
7.6.1 South America Hematology and Coagulation Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Hematology and Coagulation Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Hematology and Coagulation Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Hematology and Coagulation Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Hematology and Coagulation Market Size, 2018-2029
8.3.2 By Company, U.S. Hematology and Coagulation Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Hematology and Coagulation Market Size, 2018-2029
8.4.2 By Company, Europe Hematology and Coagulation Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Hematology and Coagulation Market Size, 2018-2029
8.5.2 By Company, China Hematology and Coagulation Revenue Market Share, 2018-2023
8.5.3 By Type, China Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Hematology and Coagulation Market Size, 2018-2029
8.6.2 By Company, Japan Hematology and Coagulation Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Hematology and Coagulation Market Size, 2018-2029
8.7.2 By Company, South Korea Hematology and Coagulation Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Hematology and Coagulation Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Hematology and Coagulation Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Hematology and Coagulation Market Size, 2018-2029
8.9.2 By Company, India Hematology and Coagulation Revenue Market Share, 2018-2023
8.9.3 By Type, India Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Hematology and Coagulation Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Hematology and Coagulation Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Hematology and Coagulation Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Hematology and Coagulation Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Abbott Diagnostics
9.1.1 Abbott Diagnostics Company Information, Head Office, Market Area and Industry Position
9.1.2 Abbott Diagnostics Company Profile and Main Business
9.1.3 Abbott Diagnostics Hematology and Coagulation Models, Specifications and Application
9.1.4 Abbott Diagnostics Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.1.5 Abbott Diagnostics Recent Developments
9.2 Beckman Coulter, Inc.
9.2.1 Beckman Coulter, Inc. Company Information, Head Office, Market Area and Industry Position
9.2.2 Beckman Coulter, Inc. Company Profile and Main Business
9.2.3 Beckman Coulter, Inc. Hematology and Coagulation Models, Specifications and Application
9.2.4 Beckman Coulter, Inc. Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.2.5 Beckman Coulter, Inc. Recent Developments
9.3 CellaVision AB
9.3.1 CellaVision AB Company Information, Head Office, Market Area and Industry Position
9.3.2 CellaVision AB Company Profile and Main Business
9.3.3 CellaVision AB Hematology and Coagulation Models, Specifications and Application
9.3.4 CellaVision AB Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.3.5 CellaVision AB Recent Developments
9.4 Diagnostica Stago, S.A.S.
9.4.1 Diagnostica Stago, S.A.S. Company Information, Head Office, Market Area and Industry Position
9.4.2 Diagnostica Stago, S.A.S. Company Profile and Main Business
9.4.3 Diagnostica Stago, S.A.S. Hematology and Coagulation Models, Specifications and Application
9.4.4 Diagnostica Stago, S.A.S. Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.4.5 Diagnostica Stago, S.A.S. Recent Developments
9.5 DIAGON Kft. Hungary
9.5.1 DIAGON Kft. Hungary Company Information, Head Office, Market Area and Industry Position
9.5.2 DIAGON Kft. Hungary Company Profile and Main Business
9.5.3 DIAGON Kft. Hungary Hematology and Coagulation Models, Specifications and Application
9.5.4 DIAGON Kft. Hungary Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.5.5 DIAGON Kft. Hungary Recent Developments
9.6 HemoCue
9.6.1 HemoCue Company Information, Head Office, Market Area and Industry Position
9.6.2 HemoCue Company Profile and Main Business
9.6.3 HemoCue Hematology and Coagulation Models, Specifications and Application
9.6.4 HemoCue Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.6.5 HemoCue Recent Developments
9.7 Horiba Medical
9.7.1 Horiba Medical Company Information, Head Office, Market Area and Industry Position
9.7.2 Horiba Medical Company Profile and Main Business
9.7.3 Horiba Medical Hematology and Coagulation Models, Specifications and Application
9.7.4 Horiba Medical Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.7.5 Horiba Medical Recent Developments
9.8 Medica Corporation
9.8.1 Medica Corporation Company Information, Head Office, Market Area and Industry Position
9.8.2 Medica Corporation Company Profile and Main Business
9.8.3 Medica Corporation Hematology and Coagulation Models, Specifications and Application
9.8.4 Medica Corporation Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.8.5 Medica Corporation Recent Developments
9.9 Microvisk Technologies
9.9.1 Microvisk Technologies Company Information, Head Office, Market Area and Industry Position
9.9.2 Microvisk Technologies Company Profile and Main Business
9.9.3 Microvisk Technologies Hematology and Coagulation Models, Specifications and Application
9.9.4 Microvisk Technologies Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.9.5 Microvisk Technologies Recent Developments
9.10 Mindray
9.10.1 Mindray Company Information, Head Office, Market Area and Industry Position
9.10.2 Mindray Company Profile and Main Business
9.10.3 Mindray Hematology and Coagulation Models, Specifications and Application
9.10.4 Mindray Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.10.5 Mindray Recent Developments
9.11 Roche Diagnostics
9.11.1 Roche Diagnostics Company Information, Head Office, Market Area and Industry Position
9.11.2 Roche Diagnostics Company Profile and Main Business
9.11.3 Roche Diagnostics Hematology and Coagulation Models, Specifications and Application
9.11.4 Roche Diagnostics Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.11.5 Roche Diagnostics Recent Developments
9.12 Siemens Healthineers
9.12.1 Siemens Healthineers Company Information, Head Office, Market Area and Industry Position
9.12.2 Siemens Healthineers Company Profile and Main Business
9.12.3 Siemens Healthineers Hematology and Coagulation Models, Specifications and Application
9.12.4 Siemens Healthineers Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.12.5 Siemens Healthineers Recent Developments
9.13 Sysmex Corporation
9.13.1 Sysmex Corporation Company Information, Head Office, Market Area and Industry Position
9.13.2 Sysmex Corporation Company Profile and Main Business
9.13.3 Sysmex Corporation Hematology and Coagulation Models, Specifications and Application
9.13.4 Sysmex Corporation Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.13.5 Sysmex Corporation Recent Developments
9.14 Werfen (Instrumentation Laboratory, Accriva Diagnostics)
9.14.1 Werfen (Instrumentation Laboratory, Accriva Diagnostics) Company Information, Head Office, Market Area and Industry Position
9.14.2 Werfen (Instrumentation Laboratory, Accriva Diagnostics) Company Profile and Main Business
9.14.3 Werfen (Instrumentation Laboratory, Accriva Diagnostics) Hematology and Coagulation Models, Specifications and Application
9.14.4 Werfen (Instrumentation Laboratory, Accriva Diagnostics) Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.14.5 Werfen (Instrumentation Laboratory, Accriva Diagnostics) Recent Developments
9.15 West Medica
9.15.1 West Medica Company Information, Head Office, Market Area and Industry Position
9.15.2 West Medica Company Profile and Main Business
9.15.3 West Medica Hematology and Coagulation Models, Specifications and Application
9.15.4 West Medica Hematology and Coagulation Revenue and Gross Margin, 2018-2023
9.15.5 West Medica Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Research Methodology:
Hematology and Coagulation Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|